Semaglutide is contraindicated in patients with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Common Adverse Effects According to clinical trial data, gastrointestinal effects are most frequently reported: nausea, vomiting, diarrhea, constipation, and abdominal discomfort
Symptoms of Oxidative Stress: It's internal mainly, but manifests as accelerated aging, chronic diseases, and fatigue
The core finding holds: dysesthesia is a retatrutide-specific side effect that occurs at clinically meaningful rates regardless of population
Brakenridge, S
For others, the decision to use BPC-157 should involve careful consideration of the limited evidence base, potential risks from unregulated products, and consultation with knowledgeable healthcare providers.